Make your appointment or second opinion with Dana-Farber today to meet with an onsite specialist.

Adult Patients:877-442-3324

Pediatric Patients:888-733-4662

Make Appointment OnlineInternational Patients

Online second opinions

Can’t get to Boston? Explore our Online Second Opinion service to get expert advice from Dana-Farber oncologists.

Request a second opinion

Contact & Directions

Email Dana-Farber

Main Number617-632-3000

Toll-Free Number866-408-DFCI (3324)

Maps & DirectionsContact InformationSend us a Question or Comment

How to Help

Discover the ways to give and how to get involved to support Dana-Farber.

Learn More
Give now

News Releases

  •   Email
  •   Print
  •   Share

  • A multi-institutional effort led by Dana-Farber Cancer Institute researchers has shown that high doses of vitamin D may slow the progress of metastatic colorectal cancer.

Tags: ColonCancer

  • New Dana-Farber study finds patients with blood cancers are less likely to receive hospice care at the end of life than patients with solid tumors.

Tags: EndOfLife

  • A new genomic study has identified prostate cancer mutations that may be more common in men of African-American background and which might be a step toward explaining why the disease is more prevalent and deadly in that minority group, says a report from Dana-Farber Cancer Institute.

Tags: Genomics, ProstateCancer, Genetics

  • Among patients with stage III colon cancer, consumption of nuts is associated with significantly reduced risks of disease recurrence and mortality, according to multi-institutional research led by Dana-Farber Cancer Institute scientists.

Tags: ColonCancer

  • Women in the U.S. with triple-negative breast cancer treated with neoadjuvant therapy are much more likely to choose mastectomies over breast-conserving lumpectomy treatments than are women in Europe and Asia, according to researchers at Dana-Farber.

Tags: BreastCancer

  • Dana-Farber Cancer Institute patients, families, visitors, and staff now have a new option to make purchases in and around the Longwood campus – and another way to help a friend or family member going through cancer. The Dana-Farber Care Card, a free, reloadable spending card, is now available.

Tags: PatientSupport

  • A multi-institutional study led by Dana-Farber Cancer Institute scientists has demonstrated that healthy lifestyles significantly boosted survival among patients treated with surgery and chemotherapy for stage III colon cancer.

Tags: ColonCancer

  • In a new study led by Dana-Farber researchers, the conjugate drug trastuzumab emtansine shows substantial benefit for breast cancer patients whose cancer has progressed with HER2-targeted therapy. The researchers conclude that trastuzumab emtansine should be considered the standard of care for these patients.

Tags: BreastCancer

  • Dana-Farber has been selected to receive funding from the Patient Centered Outcomes Research Institute (PCORI) for a five-year clinical trial to determine if a Shared Care program can be safe and effective in providing quality in follow-up care.

Tags: StemCellTransplant

  • Brian Wolpin, MD, MPH, has been named the new Director of the Gastrointestinal Cancer Center at Dana-Farber.

Tags: ColonCancer

Showing 1-10 of 782 items